Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US
Posted by
www.biotecnika.org
Drug firm Lupin on Monday said it has launched generic Mycophenolic
acid delayed-release tablets, which is used to prevent organ rejection
in patients receiving kidney transplants in the US market.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-drug-used-for-prevention-of-organ-rejection-in-kidney-transplant-in-us/articleshow/75006474.cms
Subscribe to:
Post Comments (Atom)
Post a Comment